Thomas H C, Pignatelli M, Lever A M
J Med Virol. 1986 May;19(1):63-9. doi: 10.1002/jmv.1890190110.
Treatment of hepatitis B virus (HBV)-infected hepatocytes with lymphoblastoid alpha-interferon (IFN) leads to an increased expression of the core antigen (HBcAg) and reduced expression of surface antigen (HBsAg). We have identified the presence of a nucleotide sequence at the start of the HBc gene in the hepatitis B virus genome similar to a consensus sequence known to occur upstream from genes induced by IFN in mammalian cells. It is possible that interferon influences the expression of the viral genes because of the presence of this homologous sequence. This sequence in the viral genome may determine the site of integration of the virus and could influence the ability of the cell containing the integrated viral sequence to respond to interferon. This "neutralisation" of the interferon system by viral integration might not only facilitate persistent infection but might also adversely affect response to alpha-interferon therapy.
用淋巴母细胞α干扰素(IFN)治疗乙型肝炎病毒(HBV)感染的肝细胞会导致核心抗原(HBcAg)表达增加,表面抗原(HBsAg)表达减少。我们已经确定在乙型肝炎病毒基因组中HBc基因起始处存在一个核苷酸序列,该序列类似于已知在哺乳动物细胞中由IFN诱导的基因上游出现的共有序列。由于存在这种同源序列,干扰素有可能影响病毒基因的表达。病毒基因组中的这个序列可能决定病毒的整合位点,并可能影响含有整合病毒序列的细胞对干扰素的反应能力。病毒整合对干扰素系统的这种“中和”作用不仅可能促进持续性感染,还可能对α干扰素治疗的反应产生不利影响。